Soc. Generale Knock-Out 22UA/ DE000SB9BTA5 /
31/05/2024 21:35:57 | Chg.+0.100 | Bid21:58:08 | Demandez à21:58:08 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
5.140EUR | +1.98% | 5.150 Bid taille: 2,000 |
5.170 Ask la taille: 2,000 |
BIONTECH SE SPON. AD... | 44.3804 - | 31/12/2078 | Call |
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02/06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
02/06
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
GlobeNewswire
02/06
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page